vs
雷诺士国际（LII）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是雷诺士国际的1.2倍（$1.4B vs $1.2B），瑞思迈净利率更高（27.6% vs 13.6%，领先14.0%），瑞思迈同比增速更快（11.0% vs -11.2%），雷诺士国际自由现金流更多（$376.7M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs 6.8%）
雷诺士国际是美国知名的暖通空调（HVAC）及制冷领域气候控制产品供应商，总部位于得克萨斯州理查森。公司在墨西哥萨尔蒂约、美国爱荷华州马歇尔敦、南卡罗来纳州奥兰治堡设有核心生产基地，1904年收购公司的诺里斯家族后裔约翰·W·诺里斯三世持有其9.8%的股份。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
LII vs RMD — 直观对比
营收规模更大
RMD
是对方的1.2倍
$1.2B
营收增速更快
RMD
高出22.1%
-11.2%
净利率更高
RMD
高出14.0%
13.6%
自由现金流更多
LII
多$65.5M
$311.2M
两年增速更快
RMD
近两年复合增速
6.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $1.4B |
| 净利润 | $162.1M | $392.6M |
| 毛利率 | 34.7% | 61.8% |
| 营业利润率 | 18.6% | 34.6% |
| 净利率 | 13.6% | 27.6% |
| 营收同比 | -11.2% | 11.0% |
| 净利润同比 | -18.0% | 13.9% |
| 每股收益（稀释后） | $4.62 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LIIRMD
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.0B | $1.2B |
净利润LIIRMD
| Q4 25 | $162.1M | $392.6M | ||
| Q3 25 | $245.8M | $348.5M | ||
| Q2 25 | $277.6M | $379.7M | ||
| Q1 25 | $120.3M | $365.0M | ||
| Q4 24 | $197.7M | $344.6M | ||
| Q3 24 | $239.0M | $311.4M | ||
| Q2 24 | $245.9M | $292.2M | ||
| Q1 24 | $124.3M | $300.5M |
毛利率LIIRMD
| Q4 25 | 34.7% | 61.8% | ||
| Q3 25 | 32.8% | 61.5% | ||
| Q2 25 | 34.8% | 60.8% | ||
| Q1 25 | 30.6% | 59.3% | ||
| Q4 24 | 33.9% | 58.6% | ||
| Q3 24 | 32.6% | 58.6% | ||
| Q2 24 | 33.6% | 58.5% | ||
| Q1 24 | 32.5% | 57.9% |
营业利润率LIIRMD
| Q4 25 | 18.6% | 34.6% | ||
| Q3 25 | 21.7% | 33.4% | ||
| Q2 25 | 23.6% | 33.7% | ||
| Q1 25 | 14.5% | 33.0% | ||
| Q4 24 | 18.2% | 32.5% | ||
| Q3 24 | 20.2% | 31.6% | ||
| Q2 24 | 22.1% | 31.2% | ||
| Q1 24 | 15.9% | 31.3% |
净利率LIIRMD
| Q4 25 | 13.6% | 27.6% | ||
| Q3 25 | 17.2% | 26.1% | ||
| Q2 25 | 18.5% | 28.2% | ||
| Q1 25 | 11.2% | 28.3% | ||
| Q4 24 | 14.7% | 26.9% | ||
| Q3 24 | 16.0% | 25.4% | ||
| Q2 24 | 16.9% | 23.9% | ||
| Q1 24 | 11.9% | 25.1% |
每股收益（稀释后）LIIRMD
| Q4 25 | $4.62 | $2.68 | ||
| Q3 25 | $6.98 | $2.37 | ||
| Q2 25 | $7.82 | $2.58 | ||
| Q1 25 | $3.37 | $2.48 | ||
| Q4 24 | $5.52 | $2.34 | ||
| Q3 24 | $6.68 | $2.11 | ||
| Q2 24 | $6.87 | $1.97 | ||
| Q1 24 | $3.47 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.7M | $1.4B |
| 总债务越低越好 | $1.1B | $403.9M |
| 股东权益账面价值 | $1.2B | $6.3B |
| 总资产 | $4.1B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.98× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资LIIRMD
| Q4 25 | $34.7M | $1.4B | ||
| Q3 25 | $59.2M | $1.4B | ||
| Q2 25 | $55.1M | $1.2B | ||
| Q1 25 | $222.9M | $932.7M | ||
| Q4 24 | $422.3M | $521.9M | ||
| Q3 24 | $255.7M | $426.4M | ||
| Q2 24 | $57.8M | $238.4M | ||
| Q1 24 | $57.6M | $237.9M |
总债务LIIRMD
| Q4 25 | $1.1B | $403.9M | ||
| Q3 25 | $838.2M | $408.7M | ||
| Q2 25 | $835.7M | $658.4M | ||
| Q1 25 | $834.2M | $663.1M | ||
| Q4 24 | $833.1M | $662.9M | ||
| Q3 24 | $827.6M | $667.6M | ||
| Q2 24 | $1.1B | $697.3M | ||
| Q1 24 | $1.2B | $997.0M |
股东权益LIIRMD
| Q4 25 | $1.2B | $6.3B | ||
| Q3 25 | $1.1B | $6.1B | ||
| Q2 25 | $900.5M | $6.0B | ||
| Q1 25 | $852.5M | $5.5B | ||
| Q4 24 | $850.2M | $5.3B | ||
| Q3 24 | $754.0M | $5.2B | ||
| Q2 24 | $577.4M | $4.9B | ||
| Q1 24 | $368.8M | $4.6B |
总资产LIIRMD
| Q4 25 | $4.1B | $8.5B | ||
| Q3 25 | $3.5B | $8.3B | ||
| Q2 25 | $3.7B | $8.2B | ||
| Q1 25 | $3.5B | $7.6B | ||
| Q4 24 | $3.5B | $7.1B | ||
| Q3 24 | $3.3B | $7.2B | ||
| Q2 24 | $3.2B | $6.9B | ||
| Q1 24 | $3.0B | $6.8B |
负债/权益比LIIRMD
| Q4 25 | 0.98× | 0.06× | ||
| Q3 25 | 0.78× | 0.07× | ||
| Q2 25 | 0.93× | 0.11× | ||
| Q1 25 | 0.98× | 0.12× | ||
| Q4 24 | 0.98× | 0.13× | ||
| Q3 24 | 1.10× | 0.13× | ||
| Q2 24 | 1.95× | 0.14× | ||
| Q1 24 | 3.13× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $405.9M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $376.7M | $311.2M |
| 自由现金流率自由现金流/营收 | 31.5% | 21.9% |
| 资本支出强度资本支出/营收 | 2.4% | 2.0% |
| 现金转化率经营现金流/净利润 | 2.50× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $638.8M | $1.8B |
8季度趋势，按日历期对齐
经营现金流LIIRMD
| Q4 25 | $405.9M | $339.7M | ||
| Q3 25 | $300.7M | $457.3M | ||
| Q2 25 | $86.8M | $538.8M | ||
| Q1 25 | $-35.8M | $578.7M | ||
| Q4 24 | $332.4M | $308.6M | ||
| Q3 24 | $452.1M | $325.5M | ||
| Q2 24 | $184.0M | $440.1M | ||
| Q1 24 | $-22.8M | $402.0M |
自由现金流LIIRMD
| Q4 25 | $376.7M | $311.2M | ||
| Q3 25 | $265.1M | $414.4M | ||
| Q2 25 | $58.3M | $508.2M | ||
| Q1 25 | $-61.3M | $557.9M | ||
| Q4 24 | $272.2M | $288.0M | ||
| Q3 24 | $410.9M | $307.7M | ||
| Q2 24 | $151.3M | $415.2M | ||
| Q1 24 | $-52.3M | $380.8M |
自由现金流率LIIRMD
| Q4 25 | 31.5% | 21.9% | ||
| Q3 25 | 18.6% | 31.0% | ||
| Q2 25 | 3.9% | 37.7% | ||
| Q1 25 | -5.7% | 43.2% | ||
| Q4 24 | 20.2% | 22.5% | ||
| Q3 24 | 27.4% | 25.1% | ||
| Q2 24 | 10.4% | 33.9% | ||
| Q1 24 | -5.0% | 31.8% |
资本支出强度LIIRMD
| Q4 25 | 2.4% | 2.0% | ||
| Q3 25 | 2.5% | 3.2% | ||
| Q2 25 | 1.9% | 2.3% | ||
| Q1 25 | 2.4% | 1.6% | ||
| Q4 24 | 4.5% | 1.6% | ||
| Q3 24 | 2.8% | 1.5% | ||
| Q2 24 | 2.3% | 2.0% | ||
| Q1 24 | 2.8% | 1.8% |
现金转化率LIIRMD
| Q4 25 | 2.50× | 0.87× | ||
| Q3 25 | 1.22× | 1.31× | ||
| Q2 25 | 0.31× | 1.42× | ||
| Q1 25 | -0.30× | 1.59× | ||
| Q4 24 | 1.68× | 0.90× | ||
| Q3 24 | 1.89× | 1.05× | ||
| Q2 24 | 0.75× | 1.51× | ||
| Q1 24 | -0.18× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LII
| Residential Heating And Cooling | $699.8M | 59% |
| Commercial Heating And Cooling | $495.2M | 41% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
